Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Work In Process (2021 - 2025)

Historic Work In Process for Dr Reddys Laboratories (RDY) over the last 5 years, with Q1 2025 value amounting to $190.8 million.

  • Dr Reddys Laboratories' Work In Process rose 1143.11% to $190.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $190.8 million, marking a year-over-year increase of 1143.11%. This contributed to the annual value of $195.5 million for FY2025, which is 1380.25% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Work In Process stood at $190.8 million for Q1 2025, which was up 1143.11% from $171.3 million recorded in Q1 2024.
  • Dr Reddys Laboratories' Work In Process' 5-year high stood at $190.8 million during Q1 2025, with a 5-year trough of $137.3 million in Q1 2021.
  • Over the past 5 years, Dr Reddys Laboratories' median Work In Process value was $171.3 million (recorded in 2024), while the average stood at $162.6 million.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Work In Process skyrocketed by 2484.09% in 2022, and later crashed by 1696.16% in 2023.
  • Over the past 5 years, Dr Reddys Laboratories' Work In Process (Quarter) stood at $137.3 million in 2021, then grew by 24.84% to $171.4 million in 2022, then fell by 16.96% to $142.3 million in 2023, then rose by 20.34% to $171.3 million in 2024, then rose by 11.43% to $190.8 million in 2025.
  • Its Work In Process stands at $190.8 million for Q1 2025, versus $171.3 million for Q1 2024 and $142.3 million for Q1 2023.